Topiramate in Neonates Receiving Whole Body Cooling for Hypoxic Ischemic Encephalopathy
Status:
Recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
The goal is to see whether topiramate (an anti-epileptic agent) improves the outcome of
babies with neonatal hypoxic encephalopathy who are receiving whole body cooling.